Comparison of the Efficacy and Side Effects of Treatment with Donepezil and Rivastigmine in the Treatment of Alzheimer's Disease by Means of Mata Analysis
碩士 === 中臺科技大學 === 醫療暨健康產業管理系碩士班 === 105 === Research background: due to the improvement of medical standards, the average life expectancy of many people; aging is almost everyone can not avoid the fact. The current population aging is also a phenomenon of globalization, followed by the increase in c...
Main Authors: | CHEN, WEI-JU, 陳薇如 |
---|---|
Other Authors: | HUANG, CHIEN-TSAI |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/e5mx5p |
Similar Items
-
Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine
by: Sarwary, Mariam
Published: (2017) -
Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
by: Dan-Dan Li, et al.
Published: (2019-05-01) -
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis
by: Richard A Hansen, et al.
Published: (2008-06-01) -
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
by: E Loveman, et al.
Published: (2006-01-01) -
QT interval prolongation and with donepezil, rivastigmine and galantamine
by: Katie Malone, et al.
Published: (2020-08-01)